ACO Name and Location
Privia Quality Network Central Florida, LLC
950 N. Glebe Rd Suite 700
Arlington, VA 22203
ACO Primary Contact
James McCoy
Office: 571-366-8850
Email: James.mccoy@priviahealth.com
Organizational Information
ACO Participants:
| Aco Participants | Aco Participant In Joint Venture |
|---|---|
| Azzam Adhal | N |
| Health First Medical Group LLC | N |
| Health First Privia Medical Group, LLC | N |
| Healthpoint Medical Group Of The Emerald Coast, LLC | N |
| Myra Reed MD PA | N |
| Pedro Ylisastigui. M.D.P.A. | N |
| Premier Family & Sports Medicine, LLC | N |
| The Family Clinic LLC | N |
ACO Governing Body:
| Member First Name | Member Last Name | Member Title/Position | *Member’s Voting Power (Expressed as a percentage) | Membership Type | ACO Participant Legal Business Name, if Applicable | ACO Participant DBA, if applicable |
|---|---|---|---|---|---|---|
| Jamie | Tavarez | Director | 10% | ACO Participant Representative | Health First Medical Group, LLC | |
| Mario | Ruberte | Director | 10% | ACO Participant Representative | Health First Medical Group, LLC | |
| Jayde | George | Director | 10% | ACO Participant Representative | Health First Medical Group, LLC | |
| David | Weldon | Director | 10% | ACO Participant Representative | Health First Medical Group, LLC | |
| Maryam | Phillips | Director | 10% | ACO Participant Representative | Health First Privia Medical Group, LLC | Dr Phillips Medical Wellness Center, LLC |
| Gary | Visser | Director | 10% | ACO Participant Representative | Health First Privia Medical Group, LLC | PremierMed Family & Sports Medicine, LLC |
| Niral | Patel | Director | 10% | ACO Participant Representative | Health First Privia Medical Group, LLC | Patel Medical Ventures, LLC |
| Timothy | Laird | Director | 10% | ACO Participant Representative | Health First Medical Group, LLC | |
| Bartley | Bryt | Director | 10% | Other | N/A | |
| Jim | Strader | Director | 10% | Medicare Beneficiary Representative | N/A |
* – Due to rounding, the members voting power total may not equal 100%
Key ACO Clinical and Administrative Leadership:
ACO Executive: James McCoy
Medical Director: Mario Ruberte, MD
Medical Director: Gary Visser, MD
Board Chair: Tim Laird, MD
Compliance Officer: Stephanie Clark
Quality Assurance/Improvement Officer: Trina Money
Associated Committees and Committee Leadership:
| Committee Name | Committee Leader Name and Position |
|---|---|
| Clinical Performance, Compliance and Governance Committee | Dr. Gary Visser, Chair |
| Funds Flow Committee | Dr. Mario Ruberte, Chair |
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangements
- Networks of individual practices of ACO professionals.
Shared Savings and Losses
Amount of Shared Savings/Losses:
- First Agreement Period
- Performance Year 2024: $12,563,826.03
- Performance Year 2023: $6,978,821
- Performance Year 2022: $3,863,349
Shared Savings Distribution
- First Agreement Period
- Performance Year 2024
- Proportion invested in infrastructure: 28.7%
- Proportion invested in redesigned care processes/resources: 4.2%
- Proportion of distribution to ACO participants: 67.1%
- Performance Year 2023
- Proportion invested in infrastructure: 10.1%
- Proportion invested in redesigned care processes/resources: 9.4%
- Proportion of distribution to ACO participants: 80.5%
- Performance Year 2022
- Proportion invested in infrastructure: 49%
- Proportion invested in redesigned care processes/resources: 4%
- Proportion of distribution to ACO participants: 47%
- Performance Year 2024
Quality Performance Results
2024 Quality Performance Results:
Quality Performance Results are based on CMS Web Interface Measure Set
| Measure # | Measure Name | Collection Type | Reported Performance Rate | Current Year Mean Performance Rate (SSP ACOs) |
|---|---|---|---|---|
| Measure # 001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | CMS Web Interface | 9.27 | 9.44 |
| Measure # 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 74.80 | 81.46 |
| Measure # 236 | Controlling High Blood Pressure | CMS Web Interface | 70.07 | 79.49 |
| Measure # 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 93.57 | 88.99 |
| Measure # 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 61.06 | 68.60 |
| Measure # 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 80.00 | 79.98 |
| Measure # 113 | Colorectal Cancer Screening | CMS Web Interface | 82.03 | 77.81 |
| Measure # 112 | Breast Cancer Screening | CMS Web Interface | 83.08 | 80.93 |
| Measure # 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 68.18 | 86.50 |
| Measure # 370 | Depression Remission at Twelve Months | CMS Web Interface | 14.89 | 17.35 |
| Measure # 321 | CAHPS for MIPS | CMS Web Interface | 7.70 | 6.67 |
| Measure # 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | CMS Web Interface | 0.1445 | 0.1517 |
| Measure # 484 | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions | CMS Web Interface | 32.40 | 37.00 |
| CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 86.52 | 83.70 |
| CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS Survey | 96.23 | 93.96 |
| CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 95.05 | 92.43 |
| CAHPS-4 | Access to Specialists | CAHPS for MIPS Survey | 78.40 | 75.76 |
| CAHPS-5 | Health Promotion and Education | CAHPS for MIPS Survey | 62.52 | 65.48 |
| CAHPS-6 | Shared Decision Making | CAHPS for MIPS Survey | 62.57 | 62.31 |
| CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS Survey | 75.32 | 74.14 |
| CAHPS-8 | Care Coordination | CAHPS for MIPS Survey | 87.44 | 85.89 |
| CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 95.20 | 92.89 |
| CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 18.86 | 26.98 |
- *For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
- *For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov
